Sunitinib N-Oxide-d10
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
Sunitinib N-Oxide-d10 Product Information
Sunitinib N-Oxide-d10 is listed under Metabolite and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-98814.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Sunitinib N-Oxide-d10
CAT No.
CS-T-98814
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C22H17D10FN4O3
Molecular Weight
424.53
Category
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
Sunitinib N-Oxide-d10 is supplied with detailed characterization data compliant with regulatory guideline. Sunitinib N-Oxide-d10 can be used for analytical method development, method validation (AMV), Quality Control (QC), ANDA-related analytical work, and commercial pharmaceutical research applications.
Overview
"Sunitinib N-Oxide-d10, is the labeled analogue Sunitinib N-Oxide (S820005), a derivative of Sunitinib (S820000), which is a multi-kinase inhibitor targeting several receptor tyrosine kinases (RTK), used for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor. It is a COVID19-related research product."
Synonyms
Sunitinib N-Oxide-d10
Application Notes
"Sunitinib N-Oxide-d10, is the labeled analogue Sunitinib N-Oxide (S820005), a derivative of Sunitinib (S820000), which is a multi-kinase inhibitor targeting several receptor tyrosine kinases (RTK), used for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor. It is a COVID19-related research product."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.